Summary of Study ST002742
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001707. The data can be accessed directly via it's Project DOI: 10.21228/M82991 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002742 |
Study Title | Differentiation of ayahuasca samples according to the origin, religious groups, and botanical varieties using multivariate statistical analysis of UHPLC-MS qualitative data |
Study Summary | Ayahuasca is a brew used by Amazonian natives for medicinal, spiritual, and cultural purposes; it is prepared by Psychotria viridis Ruiz & Pav. (Rubiaceae) leaves and Banisteriopsis caapi (Spruce ex Griseb.) Morton (Malpighiaceae) liana decoction, mainly. When considering the potential of ayahuasca as a new phytomedicine to treat depression, it is important to establish which parameters can significantly modify the composition of the brew. Therefore, we report herein statistical analyses regarding ayahuasca chemical composition from different geographic origins, religious groups, and botanical varieties of the sample. Also, we analyzed which biological pathway could be associated to the Banisteriopsis caapi varieties' emergence. Ayahuasqueiro group has more influence on sample differentiation than geographical origin. The most important identified compounds for ayahuasqueiro group brew differentiation are glycosylated and/or phenolic. The metabolic pathway with significant variation related to the Banisteriopsios caapi (Spruce ex Griseb.) Morton variety was Arginine and proline metabolism. |
Institute | University of Campinas |
Department | Chemistry's Institute |
Laboratory | Laboratory of Bioanalytics and Integrated Omics |
Last Name | Matos |
First Name | Taynara |
Address | Rua Josué de Castro, s/n, Campinas, São Paulo, 13083-970, Brazil |
t262827@dac.unicamp.br | |
Phone | 85996154192 |
Submit Date | 2023-06-12 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2024-11-05 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001707 |
Project DOI: | doi: 10.21228/M82991 |
Project Title: | Ayahuasca Samples |
Project Type: | MS untargeted analysis |
Project Summary: | Untargeted analysis on ayahuasca samples from different geographical origin, ayahuasqueiro groups, and botanical variety. |
Institute: | University of Campinas |
Department: | Chemistry's Institute |
Laboratory: | Laboratory of Bioanalytics and Integrated Omics |
Last Name: | Matos |
First Name: | Taynara |
Address: | Rua Josué de Castro, s/n, Campinas, São Paulo, 13083-970, Brazil |
Email: | t262827@dac.unicamp.br |
Phone: | 85996154192 |
Subject:
Subject ID: | SU002849 |
Subject Type: | Plant |
Subject Species: | Psychotria viridis; Banisteriopsis caapi |
Factors:
Subject type: Plant; Subject species: Psychotria viridis; Banisteriopsis caapi (Factor headings shown in green)
mb_sample_id | local_sample_id | Ayahuasqueiro group | Origin | B. caapi varity |
---|---|---|---|---|
SA288874 | cha_pos_EUR_89 | Daime estrela | EUR | Uninformed |
SA288875 | cha_neg_EUR_89 | Daime estrela | EUR | Uninformed |
SA288876 | cha_pos_EUR_18 | Daime | EUR | Uninformed |
SA288877 | cha_pos_EUR_42 | Daime | EUR | Uninformed |
SA288878 | cha_pos_EUR_118 | Daime | EUR | Uninformed |
SA288879 | cha_pos_EUR_44 | Daime | EUR | Uninformed |
SA288880 | cha_pos_EUR_16 | Daime | EUR | Uninformed |
SA288881 | cha_pos_EUR_4 | Daime | EUR | Uninformed |
SA288882 | cha_neg_EUR_16 | Daime | EUR | Uninformed |
SA288883 | cha_pos_EUR_67 | Daime | EUR | Uninformed |
SA288884 | cha_neg_EUR_4 | Daime | EUR | Uninformed |
SA288885 | cha_pos_EUR_117 | Daime | EUR | Uninformed |
SA288886 | cha_pos_EUR_8 | Daime | EUR | Uninformed |
SA288887 | cha_pos_EUR_116 | Daime | EUR | Uninformed |
SA288888 | cha_pos_EUR_104 | Daime | EUR | Uninformed |
SA288889 | cha_pos_EUR_84 | Daime | EUR | Uninformed |
SA288890 | cha_pos_EUR_82 | Daime | EUR | Uninformed |
SA288891 | cha_pos_EUR_68 | Daime | EUR | Uninformed |
SA288892 | cha_pos_EUR_105 | Daime | EUR | Uninformed |
SA288893 | cha_pos_EUR_107 | Daime | EUR | Uninformed |
SA288894 | cha_neg_EUR_18 | Daime | EUR | Uninformed |
SA288895 | cha_pos_EUR_51 | Daime | EUR | Uninformed |
SA288896 | cha_pos_EUR_110 | Daime | EUR | Uninformed |
SA288897 | cha_pos_EUR_53 | Daime | EUR | Uninformed |
SA288898 | cha_pos_EUR_48 | Daime | EUR | Uninformed |
SA288899 | cha_neg_EUR_8 | Daime | EUR | Uninformed |
SA288900 | cha_neg_EUR_68 | Daime | EUR | Uninformed |
SA288901 | cha_neg_EUR_67 | Daime | EUR | Uninformed |
SA288902 | cha_neg_EUR_104 | Daime | EUR | Uninformed |
SA288903 | cha_neg_EUR_118 | Daime | EUR | Uninformed |
SA288904 | cha_neg_EUR_107 | Daime | EUR | Uninformed |
SA288905 | cha_neg_EUR_105 | Daime | EUR | Uninformed |
SA288906 | cha_neg_EUR_84 | Daime | EUR | Uninformed |
SA288907 | cha_neg_EUR_82 | Daime | EUR | Uninformed |
SA288908 | cha_neg_EUR_110 | Daime | EUR | Uninformed |
SA288909 | cha_neg_EUR_53 | Daime | EUR | Uninformed |
SA288910 | cha_neg_EUR_117 | Daime | EUR | Uninformed |
SA288911 | cha_neg_EUR_116 | Daime | EUR | Uninformed |
SA288912 | cha_neg_EUR_51 | Daime | EUR | Uninformed |
SA288913 | cha_neg_EUR_44 | Daime | EUR | Uninformed |
SA288914 | cha_neg_EUR_42 | Daime | EUR | Uninformed |
SA288915 | cha_neg_EUR_48 | Daime | EUR | Uninformed |
SA288916 | cha_pos_EST_11 | Guided (Neoshamanic) | EST | Uninformed |
SA288917 | cha_pos_EST_6 | Guided (Neoshamanic) | EST | Uninformed |
SA288918 | cha_pos_EST_9 | Guided (Neoshamanic) | EST | Uninformed |
SA288919 | cha_pos_EST_10 | Guided (Neoshamanic) | EST | Uninformed |
SA288920 | cha_pos_EST_5 | Guided (Neoshamanic) | EST | Uninformed |
SA288921 | cha_neg_EST_5 | Guided (Neoshamanic) | EST | Uninformed |
SA288922 | cha_neg_EST_15 | Guided (Neoshamanic) | EST | Uninformed |
SA288923 | cha_neg_EST_25 | Guided (Neoshamanic) | EST | Uninformed |
SA288924 | cha_neg_EST_28 | Guided (Neoshamanic) | EST | Uninformed |
SA288925 | cha_pos_EST_25 | Guided (Neoshamanic) | EST | Uninformed |
SA288926 | cha_neg_EST_11 | Guided (Neoshamanic) | EST | Uninformed |
SA288927 | cha_neg_EST_10 | Guided (Neoshamanic) | EST | Uninformed |
SA288928 | cha_pos_EST_28 | Guided (Neoshamanic) | EST | Uninformed |
SA288929 | cha_neg_EST_6 | Guided (Neoshamanic) | EST | Uninformed |
SA288930 | cha_pos_EST_15 | Guided (Neoshamanic) | EST | Uninformed |
SA288931 | cha_neg_EST_9 | Guided (Neoshamanic) | EST | Uninformed |
SA288932 | cha_neg_EUR_103 | Hoasca UDV | EUR | Uninformed |
SA288933 | cha_pos_EUR_103 | Hoasca UDV | EUR | Uninformed |
SA288934 | cha_pos_EST_1 | Mix Shamanic + Neoshamanic | EST | Uninformed |
SA288935 | cha_neg_EST_1 | Mix Shamanic + Neoshamanic | EST | Uninformed |
SA288936 | cha_pos_EUR_1 | Mix Shamanic + Neoshamanic | EUR | Uninformed |
SA288937 | cha_neg_EUR_1 | Mix Shamanic + Neoshamanic | EUR | Uninformed |
SA288938 | cha_pos_EST_19 | Neoshamanic | EST | Uninformed |
SA288939 | cha_neg_EST_32 | Neoshamanic | EST | Uninformed |
SA288940 | cha_pos_EST_17 | Neoshamanic | EST | Uninformed |
SA288941 | cha_neg_EST_24 | Neoshamanic | EST | Uninformed |
SA288942 | cha_neg_EST_13 | Neoshamanic | EST | Uninformed |
SA288943 | cha_pos_EST_13 | Neoshamanic | EST | Uninformed |
SA288944 | cha_pos_EST_24 | Neoshamanic | EST | Uninformed |
SA288945 | cha_neg_EST_19 | Neoshamanic | EST | Uninformed |
SA288946 | cha_neg_EST_3 | Neoshamanic | EST | Uninformed |
SA288947 | cha_pos_EST_32 | Neoshamanic | EST | Uninformed |
SA288948 | cha_neg_EST_2 | Neoshamanic | EST | Uninformed |
SA288949 | cha_neg_EST_17 | Neoshamanic | EST | Uninformed |
SA288950 | cha_pos_EST_3 | Neoshamanic | EST | Uninformed |
SA288951 | cha_neg_EST_7 | Neoshamanic | EST | Uninformed |
SA288952 | cha_pos_EST_7 | Neoshamanic | EST | Uninformed |
SA288953 | cha_pos_EST_2 | Neoshamanic | EST | Uninformed |
SA289144 | cha_pos_EUR_66 | neoshamanic | EUR | Uninformed |
SA289145 | cha_neg_EUR_71 | neoshamanic | EUR | Uninformed |
SA289146 | cha_neg_EUR_64 | neoshamanic | EUR | Uninformed |
SA289147 | cha_pos_EUR_71 | neoshamanic | EUR | Uninformed |
SA289148 | cha_pos_EUR_70 | neoshamanic | EUR | Uninformed |
SA289149 | cha_pos_EUR_64 | neoshamanic | EUR | Uninformed |
SA289150 | cha_neg_EUR_66 | neoshamanic | EUR | Uninformed |
SA289151 | cha_neg_EUR_70 | neoshamanic | EUR | Uninformed |
SA288954 | cha_neg_EUR_78 | Neoshamanic | EUR | Uninformed |
SA288955 | cha_neg_EUR_80 | Neoshamanic | EUR | Uninformed |
SA288956 | cha_neg_EUR_58 | Neoshamanic | EUR | Uninformed |
SA288957 | cha_pos_EUR_88 | Neoshamanic | EUR | Uninformed |
SA288958 | cha_neg_EUR_46 | Neoshamanic | EUR | Uninformed |
SA288959 | cha_pos_EUR_90 | Neoshamanic | EUR | Uninformed |
SA288960 | cha_neg_EUR_49 | Neoshamanic | EUR | Uninformed |
SA288961 | cha_neg_EUR_88 | Neoshamanic | EUR | Uninformed |
SA288962 | cha_pos_EUR_93 | Neoshamanic | EUR | Uninformed |
SA288963 | cha_neg_EUR_106 | Neoshamanic | EUR | Uninformed |
SA288964 | cha_neg_EUR_91 | Neoshamanic | EUR | Uninformed |
SA288965 | cha_neg_EUR_90 | Neoshamanic | EUR | Uninformed |
Collection:
Collection ID: | CO002842 |
Collection Summary: | Ayahuasca samples (N= 126) were collected from ceremonies held in different countries (Estonia, Finland, Greece, USA, Brazil, and Italy) of different group’s specifications (Santo Daime, Shamanic, Neoshamanic, and União do Vegetal). The nomenclature of the samples was attributed according to previous works of the research group which was based on the provider (Kaasik et al., 2020; Souza et al., 2019). Thirty-seven (N= 37) samples were obtained from União do Vegetal/Brazil (UDV), thirty-two (N= 32) from Estonia (EST), and fifty-seven (N= 57) samples were grouped as Europe (EUR). The sample’s names (EST and EUR) were attributed based on the locality where most of the samples came from. Ayahuasca samples were stored, after collection, in 1 mL tubes in a biofreezer at -80 ºC until analysis. Kaasik, H. et al. 2020.J. Psychoactive Drugs. https://doi.org/10.1080/02791072.2020.1815911 Souza, R.C.Z. et al. 2019. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1124, 197–203. https://doi.org/10.1016/j.jchromb.2019.06.014 |
Sample Type: | Decoction |
Storage Conditions: | -80℃ |
Storage Vials: | 1 mL tubes |
Treatment:
Treatment ID: | TR002858 |
Treatment Summary: | Each sample was packed in completely filled 15 mL tubes, to avoid possible oxidative degradation. Subsequently, 1 mL aliquots were identified and conditioned at −80 °C until analysis. |
Sample Preparation:
Sampleprep ID: | SP002855 |
Sampleprep Summary: | The ayahuasca samples were thawed, conditioned at room temperature (around 25ºC), and then centrifuged for 10 min at 10,000 rpm at 25 ºC. The supernatants were then diluted in a 1:1 (v/v) methanol solution (40 µL sample + 360 µL methanol solution) and filtered in a 0.22 µm microporous polyvinylidene fluoride membrane. |
Sampleprep Protocol Filename: | SamplePrep-Ayahuasca_Matos2023.pdf |
Combined analysis:
Analysis ID | AN004445 | AN004446 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Waters Acquity | Waters Acquity |
Column | Waters ACQUITY UPLC BEH C18 (50 x 2.1mm,1.7um) | Waters ACQUITY UPLC BEH C18 (50 x 2.1mm,1.7um) |
MS Type | ESI | ESI |
MS instrument type | QTOF | QTOF |
MS instrument name | Waters Xevo-G2-XS | Waters Xevo-G2-XS |
Ion Mode | POSITIVE | NEGATIVE |
Units | Peak area | Peak area |
Chromatography:
Chromatography ID: | CH003340 |
Methods Filename: | UntargetedRP-MethodXEVOG2XS-Ayahuasca_Matos2023.pdf |
Instrument Name: | Waters Acquity |
Column Name: | Waters ACQUITY UPLC BEH C18 (50 x 2.1mm,1.7um) |
Column Temperature: | 40 |
Flow Gradient: | 0.35 mL/min: 0-3 min, 5-90% B; 3-4.5 min, 90% B; 4.5-4.6 min, 90-5% B; and 4.6-7.5 min; 5% B. |
Flow Rate: | 0.35 mL/min |
Solvent A: | Water |
Solvent B: | Acetronitrile |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS004192 |
Analysis ID: | AN004445 |
Instrument Name: | Waters Xevo-G2-XS |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | The cone gas was 50 L/h, and the source temperature was 150 ºC, and the cone voltage was 40 kV. MS data were acquired in the centroid mode from mass spectra range was m/z 50-1000 Da, and the scan time was 0.5 seg/scan using the MSE approach (6 V for low-energy, and a 10- 30 V ramp for high-energy scanning). During MS analysis, a leucine enkephalin (Waters®, molecular mass = 555.62; 200 pg/μL in 1:1 ACN: H2O) was continuously infused into MS at a flow rate of 30 µL/min, and the ions [M-H]- = 554.26 e [M+H]+ = 556.27 were used as a lock mass for accurate mass measurement. Data acquisition was controlled by MassLynx V4.2 (Waters®). Calibration was performed before sample analysis via infusion of 0.5 mmol/L sodium formate solution, which was used for calibration procedures. The data matrix exported from the Progenesis QI 2.0 software (Waters, Milford, MA, USA) contained retention time, m/z, and intensity of each feature with sample and groups’ names were uploaded on the Generic Format module of MetaboAnalyst 5.0. |
Ion Mode: | POSITIVE |
Capillary Voltage: | +3.0 kV |
Desolvation Gas Flow: | 600 L/h |
Desolvation Temperature: | 400 °C |
Analysis Protocol File: | UntargetedRP-MethodXEVOG2XS-Ayahuasca_Matos2023.pdf |
MS ID: | MS004193 |
Analysis ID: | AN004446 |
Instrument Name: | Waters Xevo-G2-XS |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | The cone gas was 50 L/h, and the source temperature was 150 ºC, and the cone voltage was 40 kV. MS data were acquired in the centroid mode from mass spectra range was m/z 50-1000 Da, and the scan time was 0.5 seg/scan using the MSE approach (6 V for low-energy, and a 10- 30 V ramp for high-energy scanning). During MS analysis, a leucine enkephalin (Waters®, molecular mass = 555.62; 200 pg/μL in 1:1 ACN: H2O) was continuously infused into MS at a flow rate of 30 µL/min, and the ions [M-H]- = 554.26 e [M+H]+ = 556.27 were used as a lock mass for accurate mass measurement. Data acquisition was controlled by MassLynx V4.2 (Waters®). Calibration was performed before sample analysis via infusion of 0.5 mmol/L sodium formate solution, which was used for calibration procedures. The data matrix exported from the Progenesis QI 2.0 software (Waters, Milford, MA, USA) contained retention time, m/z, and intensity of each feature with sample and groups’ names were uploaded on the Generic Format module of MetaboAnalyst 5.0. |
Ion Mode: | NEGATIVE |
Capillary Voltage: | -2.5 kV |
Desolvation Gas Flow: | 600 L/h |
Desolvation Temperature: | 400 °C |
Analysis Protocol File: | UntargetedRP-MethodXEVOG2XS-Ayahuasca_Matos2023.pdf |